Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2014


we.CONECT presents the ener.CON Award 2014

20 Mar 2014 - 21 Mar 2014 - Berlin, Germany



Bookmark and Share


For the first time we.CONECT bestows the ener.CON Award for the best energy efficiency project. The Award Ceremony will be part of the ener.CON Europe 2014 conference, taking place on March 20 – 21, 2014 in Berlin. The Award will be given to outstanding achievements and performance in Strategy & Management, Technology or Innovation. Advisory Board | Jury The ener.con AWARD 2014 is judged by a selected panel of expert professionals from a diverse range of sectors and is composed of the members of the event’s advisory board. Members of the advisory board include: • Michael Becker, Director Pfizer Global Engineering, Pfizer Inc. / Germany • Malte Homann, Global Energy Excellence Manager, Bayer Material Science AG / Germany • Bart Adams, Principal Consultant Sustainable Use, Head of Section, DNV KEMA / Belgium Boost your Project If you strive to see your project honored and celebrated by a thriving community, then don’t hesitate to apply for the ener.con AWARD 2014! Earn the recognition and reputation your project deserves and promote your concept among peers! Apply now for the ener.con AWARD 2014: http://www.we-conect.com/cms/media/uploads/events/435/dokumente/1403_enerCONAWARD_2014_application_interaktiv.pdf Download the application form, fill all information about your company and your project in and send it back to peter.haack@we-conect.com or fax it to +49 (0) 30 52 10 70 3 – 30 until February 25, 2014. In winning the ener.con AWARD 2014, the selected project will not only receive a certificate and respective trophy, but also enable the donation of a 2.000,00 Euro cheque on the company’s behalf to a corresponding charity project, as organized by we.CONECT. If you want to receive more information about the conditions of the award, the award ceremony or the ener.CON Europe 2014 conference, you are welcome to visit our website (http://enercon2014.we-conect.com/en/preview/award) or contact us: Peter Haack Marketing Development Commander Phone: +49 (0)30 52 10 70 3 - 42| Fax: +49 (0)30 52 10 70 3 - 30 Email: peter.haack@we-conect.com www.we-conect.com

Further information
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!